News & Updates
Filter by Specialty:
Daratumumab-containing regimens safe, effective against multiple myeloma
21 Nov 2021
Adding daratumumab to backbone treatments against multiple myeloma (MM) yields high clinical efficacy and has an acceptable toxicity profile, a recent study has found. Such regimens are good treatment options for newly diagnosed (ND) and relapsed/refractory (RR) MM.